Ms. Sayali Kulkarni | Medicine and Dentistry | Editorial Board Member

Published on by Citation Awards

Ms. Sayali Kulkarni | Medicine and Dentistry | Editorial Board Member

Georgian National University SEU | Georgia

Ms. Sayali Kulkarni is an emerging researcher with a strong foundation in medical sciences, recognized for her determination, disciplined work ethic, and commitment to continuous learning. She demonstrates a proactive approach to expanding her knowledge and shows significant potential for contributing to academic and clinical research. Her effective communication and interpersonal skills support collaborative work and the translation of research into patient-centered outcomes. As an early-career professional, she reflects the core values of research excellence and holds promise for meaningful contributions to the field.

View Orcid Profile

Featured Publications

Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

The Second Affiliated Hospital of Nanjing Medical University | China

Dr. Xiaofeng Shi is a Chinese medical professional and researcher with a strong academic background in medicine and hematology. He earned his Bachelor’s degree from Jiangsu University, followed by a Master’s degree from the School of Medicine at Suzhou University. He later completed his doctoral studies in the Department of Hematology at Shanghai Jiao Tong University School of Medicine. His academic training reflects a focused expertise in medical sciences, particularly in the field of hematology, contributing to clinical research and healthcare advancement.

Citation Metrics (Scopus)

600450

300

150

0

Citations
563
Documents
51
h-index
10

VIEW SCOPUS PROFILE

Featured Publications


Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

– American Journal of Hematology, 2025

Nomogram for predicting the 30- and 90-day prognoses of hemophagocytic lymphohistiocytosis patients: a multicenter and retrospective study

– Annals of Hematology, 2025

Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels

– Scientific Reports, 2025

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNS)

– Review, 2025

ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes

– Review, 2025

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

University of Bari Aldo Moro | Italy

Prof. Fabio Sallustio is an Associate Professor in Applied Medical Technical Science at the University of Bari “Aldo Moro,” where he conducts advanced research in renal biology and kidney diseases. His work primarily focuses on the genomic and functional characterization of adult renal stem/progenitor cells and their role in kidney repair, as well as the cellular and molecular mechanisms underlying kidney disorders, particularly IgA nephropathy. He has made significant contributions to understanding how renal progenitor cells activate reparative processes, including identifying key pathways such as Toll-like receptor 2–mediated signaling and their role in tissue regeneration, fibrosis prevention, and immunomodulation. In parallel, his research on IgA nephropathy has advanced knowledge of disease pathogenesis through the identification of dysregulated molecular pathways, epigenetic alterations, and genetic variations. He leads a multidisciplinary research team and actively supervises students and doctoral researchers in the fields of medical biotechnology and molecular medicine.

Citation Metrics (Scopus)

30002000

1000

500

0

Citations
2,697
Documents
96
h-index
32

VIEW SCOPUS PROFILE
 VIEW Orcid PROFILE
 VIEW Google Scholar PROFILE

Featured Publications

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Université Paris Cité | France

Prof. Bruno Megarbane is a Professor at Université Paris Cité and serves as Head of the Department of Medical and Toxicological Critical Care at Lariboisière University Hospital. He is also a research team leader within the experimental research group at INSERM UMRS-1144. In addition, he acts as the medical head of the regional and national reference centre for chemicals, toxins, and toxicants (CORTOX), contributing to national health preparedness under the French General Direction of Health. His work primarily focuses on clinical toxicology, including drug poisoning, substance abuse, and envenomation.

Citation Metrics (Google Scholar)

40,00030,000

20,000

10,000

0

Citations

35,281

i10-index

402

h-index

90

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile
 View PubMed Profile

Featured Publications


A communication strategy and brochure for relatives of patients dying in the ICU

– New England Journal of Medicine, 2007 (Cited by 1743)

High versus low blood-pressure target in patients with septic shock

– New England Journal of Medicine, 2014 (Cited by 1474)

Initiation strategies for renal-replacement therapy in the intensive care unit

– New England Journal of Medicine, 2016 (Cited by 1415)

Hydrocortisone plus fludrocortisone for adults with septic shock

– New England Journal of Medicine, 2018 (Cited by 1038)

Xiangyu Zhong | Medicine | Best Researcher Award

Published on by Citation Awards

Prof. Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong, The 2nd Affiliated Hospital of Harbin Medical University, China

Professor Xiangyu Zhong is a distinguished academic and chief physician at the Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China. With a robust background in medicine and extensive clinical experience, his research primarily focuses on cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury.

Professional Profiles:

Scopus

Professional Experience:

Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.

Research Interests:

Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.

Contributions and Impact:

Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.

Publications:

Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141

Open access

0 citations

Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134

Open access

1 citation

Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780

Open access

1 citation

Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309

Open access

1 citation

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228

Open access

0 citations

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45

Open access

0 citations

Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620

Open access

5 citations

Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779

Retraction

0 citations

Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096

Open access

1 citation

Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360

Open access

1 citation

Conclusion:

Prof. Xiangyu Zhong is undoubtedly a strong contender for the Best Researcher Award due to his extensive research contributions, leadership in collaborative efforts, and impact on medical and therapeutic advancements. While there are areas where improvement could further elevate his profile, such as increasing citations and expanding clinical research involvement, his overall academic impact, innovation, and leadership make him a deserving candidate. His work not only contributes to fundamental science but also holds significant promise for improving patient care and treatment outcomes, which is at the core of the Best Researcher Award’s mission.